FDA approves Palomar's anti-wrinkle device; shares soar Reuters The device was developed by Palomar and completed together with Johnson and Johnson Consumer Cos, under a previously announced deal to develop light-based anti-aging devices, the company said in a statement. Palomar shares were up 58 percent at $17.35 ... Palomar gets FDA's OTC clearance for wrinkle treatment device ... Palomar Receives FDA Over-The-Counter Clearance for a Home Use ... |
No comments:
Post a Comment